Literature DB >> 13452842

Whole body x-irradiation of experimental animals; a short summary of the methods used at the M.R.C. Radiobiological Research Unit, A.E.R.E., Harwell, between 1949-1956.

M J CORP.   

Abstract

Keywords:  LABORATORY ANIMALS; ROENTGEN RAYS

Mesh:

Year:  1957        PMID: 13452842     DOI: 10.1088/0031-9155/1/4/306

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


× No keyword cloud information.
  8 in total

1.  Study of the antigenic constituents of sera from mouse/rat chimaeras.

Authors:  P GRABAR; J COURCON; D W BARNES; C E FORD; H S MICKLEM
Journal:  Immunology       Date:  1962-11       Impact factor: 7.397

2.  The treatment of acutely x-irradiated mice with streptomycin and derivatives of 6-aminopenicillanic acid.

Authors:  T L FALLOWFIELD
Journal:  Br J Exp Pathol       Date:  1962-02

3.  Transplantation immunity in the isologous mouse radiation chimaera.

Authors:  J B BRIDGES; J F LOUTIT; H S MICKLEM
Journal:  Immunology       Date:  1960-07       Impact factor: 7.397

4.  Rejection of skin grafts and production of specific iso-haemagglutinins by normal and x-irradiated mice.

Authors:  H S MICKLEM; J A BROWN
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

5.  Active and passive immunity to transplantation of foreign bone marrow in lethally irradiated mice.

Authors:  J F LOUTIT; H S MICKLEM
Journal:  Br J Exp Pathol       Date:  1961-12

6.  A local graft-versus-host reaction following intradermal injection of lymphocytes in the rat.

Authors:  W L Ford
Journal:  Br J Exp Pathol       Date:  1967-06

7.  The total white cell count of the blood as indicator of acute radiation damage and its value during the first few hours after exposure.

Authors:  E V HULSE
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

8.  The dose-response for x-ray induction of myeloid leukaemia in male CBA/H mice.

Authors:  R H Mole; D G Papworth; M J Corp
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.